Related Experiment Video
Updated: Dec 29, 2025

A Soluble Tetrazolium-Based Reduction Assay to Evaluate the Effect of Antibodies on Candida tropicalis Biofilms
Published on: September 16, 2022
Virulence and biofilms as promising targets in developing antipathogenic drugs against candidiasis
Mohd Sajjad Ahmad Khan1, Fatimah Alshehrei2, Saleh Bakheet Al-Ghamdi3
1Department of Basic Sciences, Imam Abdulrahman Bin Faisal University, Dammam, Saudi Arabia.
Abstract:
Candida albicans has remained the main etiological agent of candidiasis, challenges clinicians with high mortality and morbidity. The emergence of resistance to antifungal drugs, toxicity and lower efficacy have all contributed to an urgent need to develop alternative drugs aiming at novel targets in C. albicans. Targeting the production of virulence factors, which are essential processes for infectious agents, represents an attractive substitute for the development of newer anti-infectives. The present review highlights the recent developments made in the understanding of the pathogenicity of C. albicans. Production of hydrolytic enzymes, morphogenesis and biofilm formation, along with their molecular and metabolic regulation in Candida are discussed with regard to the development of novel antipathogenic drugs against candidiasis.
Insights
Drug resistance in Candida albicans necessitates new treatments. Targeting virulence factors like enzymes, morphogenesis, and biofilms offers a promising strategy for novel antifungal drug development.
Area of Science:
- Microbiology
- Infectious Diseases
- Drug Discovery
Background:
- Candida albicans is a primary cause of candidiasis, leading to significant mortality and morbidity.
- Existing antifungal drugs face challenges due to resistance, toxicity, and reduced efficacy.
Purpose of the Study:
- To review recent advancements in understanding Candida albicans pathogenicity.
- To explore novel drug targets for combating candidiasis.
Main Methods:
- Literature review focusing on virulence factors and their regulation.
- Analysis of molecular and metabolic pathways involved in pathogenicity.
Main Results:
- Virulence factors such as hydrolytic enzymes, morphogenesis, and biofilm formation are crucial for C. albicans infection.
- Understanding the regulation of these factors provides insights for therapeutic intervention.
Conclusions:
- Targeting virulence factor production is a viable alternative strategy for developing new anti-infectives.
- Further research into the molecular regulation of C. albicans pathogenicity can guide novel drug design.
Related Concept Videos
Biofilms
Gene Regulation in Microbial Communities: Quorum Sensing

